TITLE:
Evaluation of the Bioavailability of Pramlintide

CONDITION:
Diabetes Mellitus, Type 1

INTERVENTION:
Pramlintide acetate

SUMMARY:

      This is a randomized, open-label, crossover study to examine the bioavailability of
      pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes
      mellitus using insulin.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 70 Years
Criteria:

        Inclusion Criteria:

          -  HbA1c value between 6-12%

          -  BMI <= 27 kg/m2 or BMI >=30 to <= 45 kg/m2

          -  Consistent insulin regimen for 2 months prior to screening
      
